Produktname:6-(Methoxymethyl)-2-phenylpyrimidin-4(3H)-one
IUPAC Name:6-(methoxymethyl)-2-phenyl-3,4-dihydropyrimidin-4-one
- CAS:339278-89-6
- Molekulare Formel:C12H12N2O2
- Reinheit:95%
- Katalognummer:CM309130
- Molekulargewicht:216.24
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:339278-89-6
- Molekulare Formel:C12H12N2O2
- Schmelzpunkt:-
- SMILES-Code:O=C1NC(C2=CC=CC=C2)=NC(COC)=C1
- Dichte:
- Katalognummer:CM309130
- Molekulargewicht:216.24
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:Store at 2-8°C.
Category Infos
- Pyrimidines
- Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.
Column Infos
- Selatogrel
- Selatogrel is an investigational, potent, fast-acting, reversible, and highly selective P2Y12 inhibitor, being developed for the treatment of an acute myocardial infarction (AMI) in patients with a recent history of AMI. It is intended to be self-administered subcutaneously via a drug delivery system (autoinjector).
This novel, self-administered emergency agent has the potential to protect heart muscle in the very early phase of an AMI – in the crucial time between symptom onset and first medical attention – so as to treat the ongoing AMI and prevent early death.